Is pharmacological prevention of Alzheimer's a realistic goal?
Authors:
- 1 April 2002
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 3 (4) , 365-380
Abstract
A growing body of evidence suggests that several classes of drugs marketed for other indications may be effective in the prevention of Alzheimer’s disease. Among the most promising of these are nonsteroidal anti-inflammatory agents, oestrogens (oestrogen replacement therapy) and antioxidant vitamins. Other less well-established candidates include histamine H2 receptor antagonists (H2 blockers) and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). For each of these, we discuss possible mechanisms for their postulated neuroprotective effects and review the studies suggesting their benefits in Alzheimer’s disease. We conclude that non-steroidal anti-inflammatory drugs and oestrogen replacement therapies may be effective in preventing Alzheimer’s disease only if taken during the latent phase of the disease several years prior to the appearance of disturbances. Antioxidants may also prevent Alzheimer’s disease, but unlike non-steroidal anti-inflammatory drugs and oestrogen replacement thera...Keywords
This publication has 180 references indexed in Scilit:
- Molecular mechanisms associated with long-term consolidation of the NMDA signalsLife Sciences, 2000
- Systemic Oxidative Stress and Cognitive Performance in the Population-Based EVA StudyFree Radical Biology and Medicine, 1998
- Low concentrations of estradiol reduce β-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cellsBrain Research, 1997
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- 17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in VitroBiochemical and Biophysical Research Communications, 1995
- Platelets Are the Primary Source of Amyloid β-Peptide in Human BloodBiochemical and Biophysical Research Communications, 1995
- Activation of Macrophages by Alzheimer β Amyloid PeptideBiochemical and Biophysical Research Communications, 1994
- Estrogen as a growth factor to central nervous cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- The increasing prevalence of mental disorders: A pandemic threatPsychiatric Quarterly, 1983